Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 784-786

  Den Hollander, Jan G ^a   Mouton, Johan W ^a,b   Van Goor, Mary Lou P J ^b   Vleggaar, Frank P ^b   Verbrugh, Henri A ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; TOBRAMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; COMPARTMENT MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0030060345     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.784     Document Type: Article

References (20)

1. Craig, W. A. 1993. Post-antibiotic effects in experimental infection models relationship to in-vitro phenomena and to treatment of infections in man. J Antimicrob. Chemother. 31(Suppl. D):149-158.
2. Craig, W. A., and S. C. Ebert. 1991. Killing and regrowth of bacteria in vitro. a review. Scand. J. Infect Dis 74(Suppl.):63-70.
3. Craig, W. A., and S. Gudmundsson. 1986. The postantibiotic effect, p 515-536. In V. Lorian (ed.), Antibiotics in laboratory medicine - 1986, 2nd ed. The Williams and Wilkins Co., Baltimore.
4. Craig, W. A., J. Redington, and S. C. Ebert. 1991. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. J. Antimicrob Chemother. 27(Suppl C):29-40.
5. den Hollander, J. G., J. W. Mouton, I. A. J. M. Bakker-Woudenberg, F. P. Vleggaar, M. P. J. van Goor, and H. A. Verbrugh. 1996. Enzymatic method for inactivation of aminoglycosides during measurement of postantibiotic effect. Antimicrob. Agents Chemother. 40:488-490.
6. Gilbert, D. N. 1991. Once-daily aminoglycoside therapy. Antimicrob. Agents Chemother. 35:399-405.
7. Isaksson, B., L. Nilsson, R. Maller, and L. Soren. 1988 Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method J Antimicrob. Chemother. 22:23-33.
8. Kapusnik, J. E., C. J. Hackbarth, H. F. Chambers, T. Carpenter, and M. A. Sande. 1988. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia. J. Infect. Dis 158:7-12
9. Karlowsky, J. A., G. G. Zhanel, R. J. Davidson, and D. J. Hoban. 1994 Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposure. J. Antimicrob. Chemother. 33:937-947.
10. Karlowsky, J. A., G. G. Zhanel, R. J. Davidson, and D. J. Hoban. 1994. Once-daily aminoglycoside dosing assessed by MIC revision time with Pseudomonas aeruginosa Antimicrob. Agents Chemother. 38:1165-1168.
11. Karlowsky, J. A., G. G. Zhanel, R. J. Davidson, S. R. Zieroth, and D. J. Hoban. 1993. In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth. Antimicrob. Agents Chemother. 37:1154-1157.
12. Leitner, F., and K. E. Price. 1982. Aminoglycosides under development, p. 29-36. In A. Whelton and H C. Neu (ed.), The aminoglycosides, 1st ed Marcel Dekker Inc., New York.
13. McGrath, B. J., C. R. Marchbanks, D. Gilbert, and M. N. Dudley. 1993. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin. Antimicrob. Agents Chemother. 37:1723-1725.
14. Mouton, J. W., and J. G. den Hollander. 1994. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ccftazidime in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 38:931-936
15. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Nicolau, D. P., C. D. Freeman, P. B. Belliveau, C. H. Nightingale, J. W. Ross, and R. Quintiliani. 1995 Experience with a once-daily aminoglycoside program administered to 2,184 adult patients Antimicrob. Agents Chemother. 39:650-655.
17. Odenholt-Tornqvist, I., E. Lowdin, and O. Cars. 1992. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36:1852-1858.
18. SAS Institute Inc. 1990. SAS users guide. SAS Institute Inc., Cary, N.C.
19. Ter Braak, E. W., P. J. de Vries, K. P. Bouter, S. G. van der Vegt, G. C. Dorrestein, J. W. Nortier, A. van Dijh, R. P. Verkooyen, and H. A. Verbrugh. 1990. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: a comparative trial with netilmicin plus ceftriaxone. Am. J. Med. 89:58-66.
20. Vogelman, B., S. Gudmundsson, J. Turnidge, J. Leggett, and W. A. Craig. 1988. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect. Dis. 157:287-298